ArticleBiomedical reports2026
Potential effect and mechanism of ultrashort wave therapy in mice with chronic rhinosinusitis.
Article in Biomedical reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhinosinusitis is an inflammatory condition that impacts both the nasal passages and the paranasal sinuses. Currently, there is no systematic or standardized treatment protocol for paediatric chronic rhinosinusitis (CRS). The aim of the present study was to conduct a preliminary investigation of the role and mechanism of ultrashort wave therapy in mice with CRS. Haematoxylin and eosin staining was performed to observe histopathological changes. Terminal deoxynucleotidyl transferase nick-end labelling assay was used to assess apoptosis in the sinus mucosa. Both immunofluorescence and enzyme-linked immunosorbent assay were performed to evaluate the expression levels of IFN-γ, IL-1α, TNF-α, and IL-10. Proteins associated with the p38/JNK/ERK signalling pathway were assessed using western blotting. The results revealed that ultrashort wave therapy significantly improved the histopathology of the sinus mucosa, particularly in maintaining the integrity of the ciliary structures. In addition, ultrashort wave therapy stimulated a notable decrease in apoptosis and inflammation in sinus mucosa samples. The phosphorylation levels of p38, JNK, and ERK were markedly inhibited in the sinus mucosa of mice with CRS subjected to ultrashort wave intervention. The findings of the present study elucidate a preliminary mechanism underlying the effects of ultrashort wave therapy on CRS progression. This suggests that ultrashort waves may be conducive to maintaining the integrity of the ciliary structures, inhibiting apoptosis, and reducing inflammation in the sinus mucosa. These effects are likely mediated through the inhibition of the p38/JNK/ERK signalling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.